Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE50.6200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots50.0000/ 1
- Ask / Lots55.0000/ 1
- Open / Previous Close0.0000 / 50.6200
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 2261 | 51.35 |
| 09:34 ET | 100 | 51.305 |
| 09:36 ET | 400 | 50.91 |
| 09:38 ET | 100 | 50.58 |
| 09:39 ET | 100 | 50.965 |
| 09:41 ET | 200 | 50.78 |
| 09:43 ET | 300 | 50.84 |
| 09:45 ET | 300 | 50.95 |
| 09:48 ET | 500 | 50.95 |
| 09:50 ET | 200 | 50.87 |
| 09:52 ET | 300 | 50.875 |
| 09:54 ET | 200 | 50.8925 |
| 09:59 ET | 1100 | 50.915 |
| 10:01 ET | 600 | 50.9275 |
| 10:03 ET | 1400 | 51.05 |
| 10:06 ET | 400 | 51.14 |
| 10:08 ET | 100 | 51.06 |
| 10:10 ET | 700 | 51.025 |
| 10:14 ET | 1208 | 50.78 |
| 10:15 ET | 100 | 50.78 |
| 10:19 ET | 200 | 50.76 |
| 10:21 ET | 1000 | 50.71 |
| 10:24 ET | 400 | 50.67 |
| 10:26 ET | 1242 | 50.575 |
| 10:28 ET | 100 | 50.665 |
| 10:30 ET | 3762 | 50.7 |
| 10:32 ET | 7104 | 50.56 |
| 10:33 ET | 14594 | 50.54 |
| 10:35 ET | 2940 | 50.55 |
| 10:37 ET | 6416 | 50.57 |
| 10:39 ET | 5410 | 50.53 |
| 10:42 ET | 11573 | 50.51 |
| 10:44 ET | 2800 | 50.5 |
| 10:46 ET | 3500 | 50.505 |
| 10:48 ET | 1856 | 50.605 |
| 10:51 ET | 300 | 50.635 |
| 10:53 ET | 800 | 50.6 |
| 10:55 ET | 1400 | 50.97 |
| 10:57 ET | 2067 | 50.81 |
| 11:00 ET | 600 | 50.77 |
| 11:02 ET | 200 | 50.77 |
| 11:04 ET | 400 | 50.81 |
| 11:06 ET | 1368 | 50.91 |
| 11:11 ET | 1175 | 50.69 |
| 11:13 ET | 808 | 50.71 |
| 11:15 ET | 2440 | 50.76 |
| 11:18 ET | 300 | 50.79 |
| 11:22 ET | 3739 | 50.83 |
| 11:26 ET | 760 | 50.84 |
| 11:27 ET | 100 | 50.97 |
| 11:29 ET | 508 | 51.03 |
| 11:31 ET | 800 | 51.03 |
| 11:33 ET | 100 | 51 |
| 11:38 ET | 219 | 51.07 |
| 11:40 ET | 1400 | 51.04 |
| 11:42 ET | 204 | 51.09 |
| 11:44 ET | 600 | 51.08 |
| 11:47 ET | 600 | 51.005 |
| 11:51 ET | 608 | 51.11 |
| 11:56 ET | 688 | 51.03 |
| 11:58 ET | 300 | 51.05 |
| 12:00 ET | 100 | 51.025 |
| 12:02 ET | 300 | 50.95 |
| 12:03 ET | 200 | 50.93 |
| 12:09 ET | 1300 | 51.08 |
| 12:12 ET | 100 | 51.065 |
| 12:14 ET | 100 | 51.11 |
| 12:16 ET | 6100 | 51 |
| 12:18 ET | 28178 | 51.04 |
| 12:20 ET | 18410 | 51 |
| 12:21 ET | 9499 | 51.02 |
| 12:23 ET | 1100 | 50.945 |
| 12:25 ET | 300 | 50.99 |
| 12:27 ET | 1708 | 51.11 |
| 12:30 ET | 1251 | 51.01 |
| 12:34 ET | 200 | 51.07 |
| 12:36 ET | 700 | 51.18 |
| 12:38 ET | 200 | 51.31 |
| 12:39 ET | 100 | 51.48 |
| 12:41 ET | 436 | 51.4 |
| 12:43 ET | 800 | 51.38 |
| 12:45 ET | 200 | 51.44 |
| 12:48 ET | 6004 | 51.23 |
| 12:50 ET | 1212 | 51.32 |
| 12:52 ET | 600 | 51.435 |
| 12:54 ET | 300 | 51.45 |
| 12:56 ET | 600 | 51.54 |
| 12:57 ET | 1448 | 51.4 |
| 12:59 ET | 362 | 51.42 |
| 01:01 ET | 300 | 51.5014 |
| 01:08 ET | 680 | 51.48 |
| 01:10 ET | 500 | 51.4925 |
| 01:12 ET | 416 | 51.49 |
| 01:14 ET | 100 | 51.42 |
| 01:15 ET | 500 | 51.52 |
| 01:17 ET | 581 | 51.54 |
| 01:19 ET | 100 | 51.52 |
| 01:21 ET | 100 | 51.52 |
| 01:28 ET | 100 | 51.515 |
| 01:32 ET | 3100 | 51.48 |
| 01:33 ET | 702 | 51.48 |
| 01:35 ET | 1339 | 51.53 |
| 01:42 ET | 1033 | 51.53 |
| 01:44 ET | 2446 | 51.41 |
| 01:46 ET | 100 | 51.45 |
| 01:48 ET | 1200 | 51.4 |
| 01:50 ET | 381 | 51.46 |
| 01:51 ET | 500 | 51.45 |
| 01:53 ET | 100 | 51.45 |
| 02:00 ET | 200 | 51.465 |
| 02:02 ET | 1421 | 51.44 |
| 02:04 ET | 1846 | 51.4 |
| 02:09 ET | 1000 | 51.29 |
| 02:11 ET | 656 | 51.365 |
| 02:13 ET | 608 | 51.4 |
| 02:15 ET | 400 | 51.37 |
| 02:20 ET | 500 | 51.33 |
| 02:24 ET | 1243 | 51.395 |
| 02:26 ET | 200 | 51.39 |
| 02:27 ET | 100 | 51.395 |
| 02:31 ET | 100 | 51.395 |
| 02:33 ET | 1000 | 51.4 |
| 02:36 ET | 1106 | 51.54 |
| 02:38 ET | 777 | 51.54 |
| 02:42 ET | 1000 | 51.545 |
| 02:44 ET | 100 | 51.53 |
| 02:45 ET | 2907 | 51.525 |
| 02:47 ET | 200 | 51.51 |
| 02:49 ET | 500 | 51.47 |
| 02:51 ET | 3416 | 51.57 |
| 02:54 ET | 1300 | 51.58 |
| 02:56 ET | 300 | 51.56 |
| 03:00 ET | 100 | 51.56 |
| 03:02 ET | 910 | 51.53 |
| 03:03 ET | 500 | 51.54 |
| 03:05 ET | 500 | 51.55 |
| 03:07 ET | 7950 | 51.4 |
| 03:09 ET | 3603 | 51.425 |
| 03:12 ET | 4516 | 51.43 |
| 03:14 ET | 321 | 51.46 |
| 03:16 ET | 1400 | 51.32 |
| 03:18 ET | 2678 | 51.225 |
| 03:20 ET | 500 | 51.225 |
| 03:21 ET | 2300 | 51.16 |
| 03:23 ET | 6333 | 51.23 |
| 03:25 ET | 2100 | 51.23 |
| 03:27 ET | 214 | 51.22 |
| 03:30 ET | 4837 | 51.11 |
| 03:32 ET | 6337 | 50.88 |
| 03:34 ET | 500 | 50.79 |
| 03:36 ET | 2063 | 50.67 |
| 03:38 ET | 325 | 50.7 |
| 03:39 ET | 922 | 50.65 |
| 03:41 ET | 2128 | 50.59 |
| 03:43 ET | 1497 | 50.715 |
| 03:45 ET | 2208 | 50.58 |
| 03:48 ET | 3529 | 50.495 |
| 03:50 ET | 4638 | 50.6 |
| 03:52 ET | 6997 | 50.68 |
| 03:54 ET | 7479 | 50.72 |
| 03:56 ET | 19957 | 50.65 |
| 03:57 ET | 14011 | 50.665 |
| 03:59 ET | 167261 | 50.62 |
May 14, 2024
DJ Crinetics Pharmaceuticals Price Target Maintained With a $65.00/Share by Cantor Fitzgerald, from 8:55AM ET on Tuesday May 14, 2024 by Dow Jones
8:55AM ET on Tuesday May 14, 2024 by Dow Jones
May 10, 2024
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 5:38PM ET on Friday May 10, 2024 by Dow Jones
5:38PM ET on Friday May 10, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Price Target Maintained With a $60.00/Share by HC Wainwright & Co., from 3:50PM ET on Friday May 10, 2024 by Dow Jones
3:50PM ET on Friday May 10, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Price Target Maintained With a $80.00/Share by JMP Securities, from 12:55PM ET on Friday May 10, 2024 by Dow Jones
12:55PM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
*DJ Crinetics Pharmaceuticals 1Q Loss/Shr 93c >CRNX, from 4:06PM ET on Thursday May 09, 2024 by Dow Jones
4:06PM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 4.0B | -13.4x | --- |
Immunovant Inc | 4.5B | -16.9x | --- |
Biohaven Ltd | 3.5B | -5.8x | --- |
Nuvalent Inc | 4.6B | -29.4x | --- |
Summit Therapeutics Inc | 3.2B | -27.4x | --- |
SpringWorks Therapeutics Inc | 3.1B | -8.3x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.0B |
|---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.68 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -13.4x |
Price/Sales (TTM) | 2,022.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
